Vaccines for children
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75D30123D16110
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Vaccines for Children Solicitation · 75D30122R72514 · Posted Jan 18, 2023
- Last date to order 100% complete
- IDV ceiling
- $1,261,504,858.94
- Maximum order
- $1,261,504,858.94
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a pharmaceutical company, to provide a range of pediatric vaccines for the Vaccines for Children (VFC) program. The $1.26 billion, multiple-award IDC has a period of performance from April 1, 2023 through March 31, 2024.
The contract aims to procure a minimum of 100 doses up to a maximum ranging from 100,000 to 13 million doses of 21 different pediatric vaccines, including DTaP, IPV, Hib, Hepatitis A and B, and HPV vaccines. Vaccines must be FDA-licensed, have a minimum 12-month shelf life, and be delivered within 15 days to CDC depots nationwide. Task orders will specify quantities and delivery schedules based on public health requirements. The contract was competed on an unrestricted basis without any set-aside designations.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$2,451 | |
| Funding Only Action | $152,874,238 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $268,272,123 | |
| Supplemental Agreement for work within scope | $72,307,434 | |
| Funding Only Action | $159,708,898 | |
| Original award | $203,726,175 |
Quick answers
Who was awarded contract 75D30123D16110?
75D30123D16110 was awarded to Glaxosmithkline, LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on April 1, 2023.
How much is contract 75D30123D16110 worth?
75D30123D16110's own ceiling is $1,261,504,859. A single order can be worth up to $1,261,504,859.
Who can order from contract 75D30123D16110?
75D30123D16110 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75D30123D16110 competed?
The extent of competition for 75D30123D16110 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV